Trials / Completed
CompletedNCT03388567
Evaluation of the Effectiveness of a Continuing Education Program in Community Pharmacies
Evaluation of the Effects of a Drug With Fiscalized Substances Dispensation, Health Education and Pharmacovigilance Continuing Education Program in Community Pharmacies: Study Protocol for a Multicenter, Cluster-randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (actual)
- Sponsor
- Universidad de Antioquia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Preventable failures in the drug chain are related to Drugs Problems Related Use and are associated with medication errors (prescription, dispensing, administration or use by the patient or caregiver), including failures In the Medication Supply System (availability and quality). The controlled drugs are those that contain substances regulated by international conventions on drug control. They are important in various fields of medicine, such as pain management, obstetric emergencies, mental disorders such as the treatment of substance dependence, psychiatry and neurology. It has been defined as abuse of drugs the improper use of these for non-medical purposes, and associated with the use without medical prescription, which can produce addiction or psychic or physical dependence.
Detailed description
Experimental study with random assignment of the staff pharmacist of Pharmacies. The staff pharmacists admitted will be followed for 12 months (1 year). The study will make it possible to determine the effect of the continuing education program accompanied by Information and Communication Technologies (ICT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Staff pharmacy whith intervention | Pharmacists who will receive continuous education through technology and communication tools, as well as accompaniment and advice from a pharmaceutical chemist |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2018-12-01
- Completion
- 2019-12-31
- First posted
- 2018-01-03
- Last updated
- 2020-04-10
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT03388567. Inclusion in this directory is not an endorsement.